What changed in this filing

/stocks — the workspaceLOADING

Item 4. Controls and Procedures

2021-08-13 compared with 2021-05-14 · 25 added, 27 removed, 5 unchanged (91% of the section changed)

2 unchanged sentences

maintain disclosure controls and procedures that are designed to ensure that information we are required to disclose in our Exchange

Act reports is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms,

and that such information is accumulated and communicated to our management, including our principal executive officer and principal

financial officer, as appropriate, to allow timely decisions regarding required disclosure.

designed and evaluate our disclosure controls and procedures recognizing that any controls and procedures, no matter how well

designed and operated, can provide only reasonable assurance and not absolute assurance of achieving the desired control objectives.

Also, the design of a control system must reflect the fact that there are resource constraints and the benefits of controls must

be considered relative to their costs.

Because of the inherent limitations in all control systems, no evaluation of controls can

provide absolute assurance that misstatements due to error or fraud will not occur or that all control issues and instances of

fraud, if any, have been detected.

These inherent limitations include the realities that judgments in decision-making can be faulty

and that breakdowns can occur because of simple error or mistake.

The design of any system of controls is based, in part, upon

certain assumptions about the likelihood of future events and there can be no assurance that any design will succeed in achieving

its stated goals under all potential future conditions.

the supervision of and with the participation of our management, including our principal executive officer and principal financial

officer, we evaluated the effectiveness of our disclosure controls and procedures, as such term is defined in Rules 13a-15(e)

and 15(d)- 15(e) promulgated under the Exchange Act as of March 31, 2021.

Based on this evaluation, our principal executive officer

and principal financial officer concluded that our disclosure controls and procedures were effective as of March 31, 2021.

Act reports is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and

that such information is accumulated and communicated to our management, including our principal executive officer and principal financial

officer, as appropriate, to allow timely decisions regarding required disclosure.

designed and evaluate our disclosure controls and procedures recognizing that any controls and procedures, no matter how well designed

and operated, can provide only reasonable assurance and not absolute assurance of achieving the desired control objectives.

design of a control system must reflect the fact that there are resource constraints and the benefits of controls must be considered

relative to their costs.

Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance

that misstatements due to error or fraud will not occur or that all control issues and instances of fraud, if any, have been detected.

These inherent limitations include the realities that judgments in decision-making can be faulty and that breakdowns can occur because

of simple error or mistake.

The design of any system of controls is based, in part, upon certain assumptions about the likelihood of

future events and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.

the supervision of and with the participation of our management, including our principal executive officer and principal financial officer,

we evaluated the effectiveness of our disclosure controls and procedures, as such term is defined in Rules 13a-15(e) and 15(d)- 15(e)

promulgated under the Exchange Act as of June 30, 2021.

Based on this evaluation, our principal executive officer and principal financial

officer concluded that our disclosure controls and procedures were effective as of June 30, 2021.

in Internal Control Over Financial Reporting

were no changes in our internal control over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act) during

the quarter ended March 31, 2021, that have materially affected, or are reasonably likely to materially affect, the Company’s

internal control over financial reporting.

NeuroOne Medical Technologies Corporation

OTHER INFORMATION

were no changes in our internal control over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act) during the quarter

ended June 30, 2021, that have materially affected, or are reasonably likely to materially affect, the Company’s internal

control over financial reporting.

Medical Technologies Corporation

II – OTHER INFORMATION

Legal Proceedings

material legal proceedings in which we are involved are discussed in Note 4, “Commitments and Contingencies,”

Notes to the Condensed Financial Statements in this Quarterly Report on Form 10-Q, and are hereby incorporated by reference.

material legal proceedings in which we are involved are discussed in Note 4, “Commitments and Contingencies,” of the Notes

to the Condensed Financial Statements in this Quarterly Report on Form 10-Q, and are hereby incorporated by reference.

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.

What changed 10-Q

Item 4. Controls and Procedures